Quarterly report pursuant to Section 13 or 15(d)

Asset Acquisition And License Agreements (Details)

v3.3.0.814
Asset Acquisition And License Agreements (Details) - Lilly - USD ($)
1 Months Ended 9 Months Ended
Feb. 28, 2015
Sep. 30, 2015
Development Milestone Commitment | Maximum    
Asset Acquisition And License Agreement Line Items    
Milestone commitment   $ 19,000,000
Sales Milestone Commitment | Maximum    
Asset Acquisition And License Agreement Line Items    
Milestone commitment   $ 30,000,000
Royalty Commitment    
Asset Acquisition And License Agreement Line Items    
Term of royalty obligation   11 years
CERC-501    
Asset Acquisition And License Agreement Line Items    
Term of the study   9 months
Accrued license fee   $ 250,000
CERC-501 | Research and development expense    
Asset Acquisition And License Agreement Line Items    
Initial payment for license fees $ 750,000  
Term of the initial payment for the license 30 days